The impact of prior platinum therapy on survival in patients with metastatic urothelial cancer receiving vinflunine

BACKGROUND: A phase III trial demonstrated an overall survival advantage with the addition of vinflunine to best supportive care (BSC) in platinum-refractory advanced urothelial cancer. We subsequently examined the impact of an additional 2 years of survival follow-up and evaluated the influence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Harshman, L C, Fougeray, R, Choueiri, T K, Schutz, F A, Salhi, Y, Rosenberg, J E, Bellmunt, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833211/
https://www.ncbi.nlm.nih.gov/pubmed/24129239
http://dx.doi.org/10.1038/bjc.2013.617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833211/
https://www.ncbi.nlm.nih.gov/pubmed/24129239
http://dx.doi.org/10.1038/bjc.2013.617

Ejemplares similares